MICROPLATE: wells coated with antihuman IgM monoclonal antibodies.\nCONJUGATE: monoclonal antibodies labelled with peroxidase, in phosphate buffer with phenol 0.05% and Bronidox 0.02%.\nPOSITIVE CONTROL: Dilueted human serum in phosphate buffer 0.01 mol/l with BSA 1% and sodium azide 0.09%.\nCONTROL CUT OFF: Diluted human serum in phosphate buffer 0.01 mol/l with BSA 1% and sodium azide 0.09%.\nIgM NEGATIVE CONTROL: Diluted Human serum in phosphate buffer 0.01 mol/l with BSA 1% and sodium azide 0.09%.\nSUBSTRATE: Tetramethylbenzidine 0.26 mg/ml and hydrogen peroxide 0.01% stabilized in citrate buffer 0.05 mol/l.\nDILUENT 50X: Protein solution concentrated 50 times with added phenol 0.05% and Bronidox 0.02%.\nWASH BUFFER 10X: Phosphate buffered saline, concentrated 10 times; contains Brij 0.5%.\nSTOP SOLUTION: H2SO4 0.3mol/l.\nANTIGEN: Purified Measles virus in phosphate buffer.\n

共有 1 個藥物證書使用此成份

申請商
美艾利爾健康股份有限公司 
適應症
含量
發證日期
2006-03-24